That decision must be based on a judicious assessment of the risk of bleeding and the risk of perioperative complications secondary to the withdrawal of the antiplatelet agent that has offered the patient adequate management before surgery.
Tal decisión debe fundamentarse en la valoración juiciosa del riesgo de sangrado y del riesgo de complicaciones perioperatorias secundarias a la suspensión del agente antiagregante que ha brindado al paciente condiciones adecuadas de manejo preoperatorias.